[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Fenfluramine.]
[G03XB02, ulipristal, The metabolism of Ulipristal can be increased when combined with Fenfluramine.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Fenfluramine.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Sulpiride is combined with Fenfluramine.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Sulthiame.]
[L01BB02, mercaptopurine, Fenfluramine may increase the excretion rate of Mercaptopurine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DA01, tacrine, The metabolism of Fenfluramine can be decreased when combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Fenfluramine.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Fenfluramine.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Fenfluramine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Tetracaine.]
[N05AE05, lurasidone, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Lurasidone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[N04BC07, apomorphine, The risk or severity of serotonin syndrome can be increased when Apomorphine is combined with Fenfluramine.]
[L04AX02, thalidomide, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA07, theobromine, Fenfluramine may increase the excretion rate of Theobromine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Fenfluramine.]
[P02CA02, thiabendazole, The metabolism of Fenfluramine can be decreased when combined with Thiabendazole.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Fenfluramine.]
[L01AC01, thiotepa, The metabolism of Fenfluramine can be decreased when combined with Thiotepa.]
[N05CA19, thiopental, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Thiopental.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Thioproperazine.]
[N05AC02, thioridazine, The risk or severity of serotonin syndrome can be increased when Thioridazine is combined with Fenfluramine.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Thiothixene.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Fenfluramine.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tiapride.]
[B01AC05, ticlopidine, The metabolism of Fenfluramine can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of serotonin syndrome can be increased when Tilidine is combined with Fenfluramine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Fenfluramine.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tolperisone.]
[N02AX02, tramadol, The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Tramadol.]
[N06AF04, tranylcypromine, The risk or severity of serotonin syndrome can be increased when Tranylcypromine is combined with Fenfluramine.]
[N06AX05, trazodone, The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Fenfluramine.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Fenfluramine.]
[C03DB02, triamterene, The metabolism of Fenfluramine can be decreased when combined with Triamterene.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Triazolam.]
[A03AB12, mepenzolate, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Trifluoperazine.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Trifluperidol.]
[N05AA05, triflupromazine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[N04AA01, trihexyphenidyl, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[A03AA05, trimebutine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Alimemazine.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Trimethadione is combined with Fenfluramine.]
[N06AA06, trimipramine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Trimipramine.]
[R06AC04, tripelennamine, The metabolism of Fenfluramine can be decreased when combined with Tripelennamine.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Fenfluramine.]
[A03BB01, butylscopolamine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[N06AX24, vilazodone, The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Fenfluramine.]
[N06AX02, tryptophan, The risk or severity of serotonin syndrome can be increased when Tryptophan is combined with Fenfluramine.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tubocurarine.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Fenfluramine.]
[L02BX03, abiraterone, The serum concentration of Fenfluramine can be increased when it is combined with Abiraterone.]
[J05AG05, rilpivirine, The metabolism of Fenfluramine can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Ezogabine.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Fenfluramine.]
[N06AX09, viloxazine, The metabolism of Fenfluramine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Fenfluramine can be decreased when combined with Vinblastine.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Fenfluramine.]
[N05AF05, zuclopenthixol, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Zuclopenthixol.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Levetiracetam.]
[L01EC01, vemurafenib, The serum concentration of Fenfluramine can be increased when it is combined with Vemurafenib.]
[J01MA13, trovafloxacin, The metabolism of Fenfluramine can be decreased when combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Drospirenone can be increased when combined with Fenfluramine.]
[G04BD07, tolterodine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Fenfluramine.]
[L03AB11, peginterferon alfa-2a, The metabolism of Fenfluramine can be decreased when combined with Peginterferon alfa-2a.]
[J02AC03, voriconazole, The metabolism of Fenfluramine can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Atracurium.]
[S01FA01, atropine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Fenfluramine.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Fenfluramine.]
[J01CA09, azlocillin, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Azlocillin.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[A08AA11, lorcaserin, The risk or severity of serotonin syndrome can be increased when Lorcaserin is combined with Fenfluramine.]
[G04BD12, mirabegron, The serum concentration of Fenfluramine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Fenfluramine can be decreased when combined with Cobicistat.]
[L04AA31, teriflunomide, The serum concentration of Fenfluramine can be decreased when it is combined with Teriflunomide.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Barbital.]
[J05AE04, nelfinavir, The metabolism of Fenfluramine can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be decreased when combined with Fenfluramine.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[N04BD02, rasagiline, The risk or severity of serotonin syndrome can be increased when Rasagiline is combined with Fenfluramine.]
[A03FA09, mosapride, The risk or severity of serotonin syndrome can be increased when Mosapride is combined with Fenfluramine.]
[N06DA02, donepezil, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Donepezil.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[N02CC03, zolmitriptan, The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Fenfluramine.]
[R06AC06, thonzylamine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, The metabolism of Fenfluramine can be decreased when combined with Darifenacin.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Diethyl ether.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Fenfluramine.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Fenfluramine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Fenfluramine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Fenfluramine can be decreased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Pomalidomide.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Fenfluramine.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Benperidol.]
[J01MA15, gemifloxacin, The metabolism of Fenfluramine can be decreased when combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The metabolism of Fenfluramine can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Fenfluramine can be decreased when combined with Celecoxib.]
[N02CC02, naratriptan, The risk or severity of serotonin syndrome can be increased when Naratriptan is combined with Fenfluramine.]
[L04AA18, everolimus, The metabolism of Fenfluramine can be decreased when combined with Everolimus.]
[N04AC01, benztropine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Fenfluramine can be decreased when it is combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Benzyl alcohol.]
[N06AX28, levomilnacipran, The risk or severity of serotonin syndrome can be increased when Levomilnacipran is combined with Fenfluramine.]
[C08EA02, bepridil, The metabolism of Bepridil can be decreased when combined with Fenfluramine.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Fenfluramine.]
[N06AX26, vortioxetine, The risk or severity of serotonin syndrome can be increased when Vortioxetine is combined with Fenfluramine.]
[G03AC08, etonogestrel, The metabolism of Etonogestrel can be increased when combined with Fenfluramine.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Fenfluramine can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Vigabatrin.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Fenfluramine.]
[C07AB04, acebutolol, The metabolism of Acebutolol can be decreased when combined with Fenfluramine.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tasimelteon.]
[L04AA32, apremilast, The metabolism of Fenfluramine can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The metabolism of Fenfluramine can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Fenfluramine.]
[L04AC11, siltuximab, The metabolism of Fenfluramine can be increased when combined with Siltuximab.]
[A03BA03, hyoscyamine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Fenfluramine.]
[L01XH04, belinostat, The metabolism of Fenfluramine can be increased when combined with Belinostat.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Alfaxalone.]
[D11AA01, glycopyrronium, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[A16AX10, eliglustat, The metabolism of Fenfluramine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Fenfluramine can be decreased when combined with Oritavancin.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Acepromazine.]
[N04AA02, biperiden, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Fenfluramine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Fenfluramine.]
[B01AA01, dicumarol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Dicoumarol.]
[N06AX11, mirtazapine, Fenfluramine may increase the serotonergic activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Fenfluramine can be increased when combined with Secukinumab.]
[L01XH03, panobinostat, The metabolism of Fenfluramine can be decreased when combined with Panobinostat.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Fenfluramine.]
[A03AA09, difemerine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[B01AA11, tioclomarol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tioclomarol.]
[J05AP06, asunaprevir, The metabolism of Fenfluramine can be decreased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The risk or severity of serotonin syndrome can be increased when Eluxadoline is combined with Fenfluramine.]
[N05AX16, brexpiprazole, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Brexpiprazole.]
[A04AD14, rolapitant, The metabolism of Fenfluramine can be decreased when combined with Rolapitant.]
[G02CX02, flibanserin, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Flibanserin.]
[N05AX15, cariprazine, The risk or severity of serotonin syndrome can be increased when Cariprazine is combined with Fenfluramine.]
[S01EC01, acetazolamide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Acetazolamide.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Acetophenazine.]
[A02BC03, lansoprazole, The metabolism of Fenfluramine can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Fenfluramine.]
[J02AC05, isavuconazole, The metabolism of Fenfluramine can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Fenfluramine can be decreased when it is combined with Osimertinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be decreased when it is combined with Fenfluramine.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Aprobarbital.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Brivaracetam.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Bromazepam.]
[N04BC01, bromocriptine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Bromocriptine.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Alverine.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Fenfluramine.]
[N06AA19, amineptin, The risk or severity of serotonin syndrome can be increased when Amineptine is combined with Fenfluramine.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Aniracetam.]
[A05AA04, obeticholic acid, The metabolism of Fenfluramine can be decreased when combined with Obeticholic acid.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Bupivacaine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Fenfluramine.]
[N07BC01, buprenorphine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Fenfluramine.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Fenfluramine.]
[N02AF01, butorphanol, The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Fenfluramine.]
[R06AX09, azatadine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Azatadine.]
[S01GX07, azelastine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Fenfluramine can be decreased when combined with Rucaparib.]
[R03DA08, bamifylline, Fenfluramine may increase the excretion rate of Bamifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Fenfluramine.]
[N02BF02, pregabalin, The therapeutic efficacy of Fenfluramine can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Beclamide.]
[N06BC01, caffeine, The metabolism of Fenfluramine can be decreased when combined with Caffeine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Oxybuprocaine.]
[J01XX08, linezolid, The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Fenfluramine.]
[J05AE09, tipranavir, The metabolism of Fenfluramine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Fenfluramine.]
[L04AB02, infliximab, The metabolism of Fenfluramine can be increased when combined with Infliximab.]
[N04BD03, safinamide, The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Fenfluramine.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Fenfluramine.]
[J05AG03, efavirenz, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Efavirenz.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Fenfluramine.]
[N04AA11, bornaprine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Bromperidol.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Brotizolam.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Butobarbital.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Fenfluramine.]
[N06AA15, butriptyline, The risk or severity of serotonin syndrome can be increased when Butriptyline is combined with Fenfluramine.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Capsaicin.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Vinylbital.]
[N03AF01, carbamazepine, The serum concentration of Fenfluramine can be decreased when it is combined with Carbamazepine.]
[A03AA03, camylofine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Carbinoxamine.]
[L03AB06, interferon alfa-n1, The metabolism of Fenfluramine can be decreased when combined with Interferon alfa-n1.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Fenfluramine.]
[N03AX24, cannabidiol, The risk or severity of serotonin syndrome can be increased when Cannabidiol is combined with Fenfluramine.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Fenfluramine.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Fenfluramine.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Fenfluramine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Fenfluramine.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Fenfluramine.]
[N03AX17, stiripentol, The serum concentration of Fenfluramine can be increased when it is combined with Stiripentol.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Fenfluramine.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Fenfluramine.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Carbromal.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Chloroprocaine.]
[R06AA06, chlorphenoxamine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[R03DA02, oxtriphylline, Fenfluramine may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Fenfluramine.]
[R03BB08, revefenacin, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L04AA39, emapalumab, The metabolism of Fenfluramine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Fenfluramine can be decreased when combined with Carmustine.]
[L01EX13, gilteritinib, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Gilteritinib.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Fenfluramine.]
[A03FA08, cinitapride, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Cinitapride.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Fenfluramine.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Esketamine.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Solriamfetol.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Brexanolone.]
[N05BA09, clobazam, The serum concentration of Fenfluramine can be increased when it is combined with Clobazam.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Cloxazolam.]
[L04AB01, etanercept, The metabolism of Fenfluramine can be increased when combined with Etanercept.]
[L01EM03, alpelisib, The metabolism of Fenfluramine can be increased when combined with Alpelisib.]
[J01DD01, cefotaxime, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Cefotaxime.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Cyamemazine.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Fenfluramine.]
[L01EJ02, fedratinib, The metabolism of Fenfluramine can be decreased when combined with Fedratinib.]
[N07XX11, pitolisant, The serum concentration of Fenfluramine can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Fenfluramine.]
[G04BE04, yohimbine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Yohimbine.]
[A10AE03, insulin, regular, pork, The metabolism of Fenfluramine can be increased when combined with Insulin pork.]
[J01DB03, cephalothin, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Cefalotin.]
[G03DB05, demegestone, The metabolism of Demegestone can be increased when combined with Fenfluramine.]
[N02CC08, lasmiditan, The risk or severity of serotonin syndrome can be increased when Lasmiditan is combined with Fenfluramine.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Fenfluramine.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be increased when combined with Fenfluramine.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Fenfluramine.]
[N03AX25, cenobamate, The serum concentration of Fenfluramine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Fenfluramine can be increased when it is combined with Givosiran.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Fenfluramine.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Fenfluramine.]
[N02AX03, dezocine, The risk or severity of serotonin syndrome can be increased when Dezocine is combined with Fenfluramine.]
[N05CM21, lemborexant, The serum concentration of Fenfluramine can be decreased when it is combined with Lemborexant.]
[N05AD10, lumateperone, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Lumateperone.]
[M01AX21, diacetylrhein, The metabolism of Fenfluramine can be decreased when combined with Diacerein.]
[S01AE06, gatifloxacin, The metabolism of Fenfluramine can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Fenfluramine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Amprenavir can be decreased when combined with Fenfluramine.]
[N02CC07, frovatriptan, The risk or severity of serotonin syndrome can be increased when Frovatriptan is combined with Fenfluramine.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Dichloralphenazone.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Fenfluramine.]
[G03DB08, dienogest, The metabolism of Dienogest can be increased when combined with Fenfluramine.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Difenoxin.]
[N02AA08, dihydrocodeine, The risk or severity of serotonin syndrome can be increased when Dihydrocodeine is combined with Fenfluramine.]
[N02CC06, eletriptan, The risk or severity of serotonin syndrome can be increased when Eletriptan is combined with Fenfluramine.]
[M01AH02, rofecoxib, The metabolism of Fenfluramine can be decreased when combined with Rofecoxib.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Fenfluramine.]
[C01BD07, dronedarone, The metabolism of Fenfluramine can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Valpromide.]
[L01AA02, chlorambucil, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Chlorambucil.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Fenfluramine.]
[A03AA08, dihexyverine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[L01EX17, capmatinib, The metabolism of Fenfluramine can be decreased when combined with Capmatinib.]
[P01BE01, artemisinin, The metabolism of Artemisinin can be decreased when combined with Fenfluramine.]
[G04BD09, trospium, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Clomethiazole.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Chlormezanone.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Dyclonine.]
[P01BB01, proguanil, The metabolism of Fenfluramine can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Remimazolam.]
[L04AC19, satralizumab, The serum concentration of Fenfluramine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Fenfluramine is combined with Oliceridine.]
[P01BA01, chloroquine, The metabolism of Fenfluramine can be decreased when combined with Chloroquine.]
[R06AB04, chlorpheniramine, The risk or severity of serotonin syndrome can be increased when Chlorpheniramine is combined with Fenfluramine.]
[N05AA01, chlorpromazine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Chlorpromazine.]
[N05AF03, chlorprothixene, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Chlorprothixene.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Fenfluramine.]
[A11CC05, cholecalciferol, The metabolism of Fenfluramine can be decreased when combined with Cholecalciferol.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Etifoxine.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Vinpocetine.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Ethyl loflazepate.]
[G03DC06, ethynodiol, The metabolism of Etynodiol can be increased when combined with Fenfluramine.]
[B06AC06, berotralstat, The metabolism of Fenfluramine can be decreased when combined with Berotralstat.]
[P03AX07, abametapir, The serum concentration of Fenfluramine can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, The metabolism of Fenfluramine can be increased when combined with Trilaciclib.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Febarbamate.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Felbamate.]
[N06BA10, fenethylline, Fenfluramine may increase the excretion rate of Fenethylline which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MB07, flumequine, The metabolism of Fenfluramine can be decreased when combined with Flumequine.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Fenfluramine.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Trichloroethylene.]
[L03AB10, peginterferon alfa-2b, The serum concentration of Fenfluramine can be increased when it is combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Fenfluramine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Gabapentin.]
[N07CA02, cinnarizine, The metabolism of Fenfluramine can be decreased when combined with Cinnarizine.]
[J01MB06, cinoxacin, The metabolism of Fenfluramine can be decreased when combined with Cinoxacin.]
[S03AA07, ciprofloxacin, The metabolism of Fenfluramine can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The metabolism of Fenfluramine can be decreased when combined with Cisplatin.]
[N06AB04, citalopram, The risk or severity of serotonin syndrome can be increased when Citalopram is combined with Fenfluramine.]
[H01AC07, somapacitan, The metabolism of Fenfluramine can be increased when combined with Somapacitan.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Fenfluramine.]
[H01AC09, lonapegsomatropin, The metabolism of Fenfluramine can be increased when combined with Lonapegsomatropin.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Fenfluramine.]
[N06AX25, St. John's wort extract, The risk or severity of serotonin syndrome can be increased when St. John's Wort is combined with Fenfluramine.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Fenfluramine.]
[B06AX04, mitapivat, The metabolism of Fenfluramine can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The metabolism of Fenfluramine can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Clomipramine.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Clonazepam.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Fenfluramine.]
[C01EB24, mavacamten, The metabolism of Fenfluramine can be increased when combined with Mavacamten.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Clothiapine.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Clotiazepam.]
[A04AA01, ondansetron, The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Fenfluramine.]
[A04AA02, granisetron, The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Fenfluramine.]
[N05AH02, clozapine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Clozapine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Halazepam.]
[H01AC08, somatrogon, The metabolism of Fenfluramine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Fenfluramine.]
[C02KB01, metyrosine, Fenfluramine may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Fenfluramine can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The risk or severity of serotonin syndrome can be increased when Codeine is combined with Fenfluramine.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Hexafluronium.]
[A03AB10, hexocyclium, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[L04AA13, leflunomide, The serum concentration of Fenfluramine can be decreased when it is combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Desflurane.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tropisetron.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Ifenprodil.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Fenfluramine.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Fenfluramine.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Desloratadine.]
[J05AB14, valganciclovir, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Valganciclovir.]
[N02CC05, almotriptan, The risk or severity of serotonin syndrome can be increased when Almotriptan is combined with Fenfluramine.]
[J02AC02, itraconazole, The metabolism of Fenfluramine can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Fenfluramine.]
[N05BA10, ketazolam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Ketazolam.]
[L01EA01, imatinib, The serum concentration of Fenfluramine can be increased when it is combined with Imatinib.]
[N03AX09, lamotrigine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[N07BC04, lofexidine, The therapeutic efficacy of Fenfluramine can be increased when used in combination with Lofexidine.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be decreased when combined with Fenfluramine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Lormetazepam.]
[H01AA02, cosyntropin, The risk or severity of liver damage can be increased when Tetracosactide is combined with Fenfluramine.]
[C08CA11, manidipine, The metabolism of Fenfluramine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Medifoxamine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Fenfluramine.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Fenfluramine.]
[R06AD04, methdilazine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Methdilazine.]
[N04AA03, methixene, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R03CB02, methoxyphenamine, The risk or severity of serotonin syndrome can be increased when Methoxyphenamine is combined with Fenfluramine.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Cyclizine.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Cyclobarbital.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Melperone.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Fenfluramine.]
[N06AX07, minaprine, The risk or severity of serotonin syndrome can be increased when Minaprine is combined with Fenfluramine.]
[S01XA18, cyclosporine, The metabolism of Fenfluramine can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of serotonin syndrome can be increased when Moclobemide is combined with Fenfluramine.]
[N06BA07, modafinil, The metabolism of Fenfluramine can be increased when combined with Armodafinil.]
[R06AX02, cyproheptadine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Cyproheptadine.]
[J05AF10, entecavir, The metabolism of Fenfluramine can be decreased when combined with Entecavir.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Fenfluramine.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Fenfluramine.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Dantrolene.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Deanol.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Fenfluramine.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[M01AX01, nabumetone, The metabolism of Fenfluramine can be decreased when combined with Nabumetone.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Nordazepam.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Fenfluramine.]
[N06AX06, nefazodone, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Niaprazine.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tiagabine.]
[G03DB04, nomegestrol, The metabolism of Nomegestrol can be increased when combined with Fenfluramine.]
[C01CA23, theodrenaline, Fenfluramine may increase the excretion rate of Theodrenaline which could result in a lower serum level and potentially a reduction in efficacy.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Fenfluramine.]
[R05DA06, normethadone, The risk or severity of serotonin syndrome can be increased when Normethadone is combined with Fenfluramine.]
[N06AB10, escitalopram, The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Escitalopram.]
[G04BD08, solifenacin, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[N06AA01, desipramine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Desipramine.]
[N03AF02, oxcarbazepine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Fenfluramine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Oxiracetam.]
[N04AA08, dexetimide, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.]
[A08AA04, dexfenfluramine, The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Fenfluramine.]
[A03AA01, oxyphencyclimine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Fenfluramine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Fenfluramine.]
[N06BA02, dextroamphetamine, The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Fenfluramine.]
[R05DA09, dextromethorphan, The risk or severity of serotonin syndrome can be increased when Dextromethorphan is combined with Fenfluramine.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Paramethadione.]
[N02AC01, dextromoramide, The risk or severity of serotonin syndrome can be increased when Dextromoramide is combined with Fenfluramine.]
[N06AB05, paroxetine, The risk or severity of serotonin syndrome can be increased when Paroxetine is combined with Fenfluramine.]
[B01AC04, clopidogrel, The metabolism of Fenfluramine can be decreased when combined with Clopidogrel.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Diamorphine.]
[C04AD01, pentifylline, Fenfluramine may increase the excretion rate of Pentifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA01, diazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Phenacemide.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Phenol.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Phensuximide.]
[N06AA08, dibenzepin, The risk or severity of serotonin syndrome can be increased when Dibenzepin is combined with Fenfluramine.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Cinchocaine.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Fenfluramine.]
[A03AA07, dicyclomine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[N05AD05, pipamperone, The risk or severity of serotonin syndrome can be increased when Pipamperone is combined with Fenfluramine.]
[A03AB14, pipenzolate, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Fenfluramine.]
[A08AA03, diethylpropion, The risk or severity of serotonin syndrome can be increased when Diethylpropion is combined with Fenfluramine.]
[L02AA01, diethylstilbestrol, The metabolism of Diethylstilbestrol can be increased when combined with Fenfluramine.]
[A03AB11, poldine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[C02DB01, dihydralazine, The metabolism of Fenfluramine can be decreased when combined with Dihydralazine.]
[N02CA01, dihydroergotamine, The risk or severity of serotonin syndrome can be increased when Dihydroergotamine is combined with Fenfluramine.]
[N02AA03, hydromorphone, The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Fenfluramine.]
[J05AE08, atazanavir, The metabolism of Fenfluramine can be decreased when combined with Atazanavir.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Fenfluramine.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Dimenhydrinate.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Pridinol.]
[R06AB03, dimethindene, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[M02AX03, dimethyl sulfoxide, The metabolism of Fenfluramine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Progabide.]
[N06BC02, propentofylline, Fenfluramine may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Proparacaine.]
[R03DA03, proxyphylline, Fenfluramine may increase the excretion rate of Proxyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AA02, diphenhydramine, The risk or severity of serotonin syndrome can be increased when Diphenhydramine is combined with Fenfluramine.]
[A07DA01, diphenoxylate, The risk or severity of serotonin syndrome can be increased when Diphenoxylate is combined with Fenfluramine.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Quazepam.]
[N06BA11, dexmethylphenidate, The risk or severity of serotonin syndrome can be increased when Dexmethylphenidate is combined with Fenfluramine.]
[N06AA23, quinupramine, The risk or severity of serotonin syndrome can be increased when Quinupramine is combined with Fenfluramine.]
[A03FA02, cisapride, The risk or severity of serotonin syndrome can be increased when Cisapride is combined with Fenfluramine.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Fenfluramine.]
[C01BA03, disopyramide, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[P03AA04, disulfiram, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Fenfluramine can be decreased when combined with Rifamycin.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Riluzole.]
[N05AX08, risperidone, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Risperidone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Levocetirizine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Ropivacaine.]
[J01MB01, rosoxacin, The metabolism of Fenfluramine can be decreased when combined with Rosoxacin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Fenfluramine.]
[C01EB18, ranolazine, The serum concentration of Fenfluramine can be increased when it is combined with Ranolazine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Fenfluramine.]
[N06AA16, dothiepin, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Dosulepin.]
[N06AA12, doxepin, The risk or severity of serotonin syndrome can be increased when Doxepin is combined with Fenfluramine.]
[L01DB01, doxorubicin, The metabolism of Fenfluramine can be decreased when combined with Doxorubicin.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[N06AB06, sertraline, The risk or severity of serotonin syndrome can be increased when Sertraline is combined with Fenfluramine.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Sevoflurane.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[A08AA10, sibutramine, The risk or severity of serotonin syndrome can be increased when Sibutramine is combined with Fenfluramine.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Fenfluramine.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Sodium phosphate, monobasic.]
[R03DA01, dyphylline, Fenfluramine may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Sultopride.]
[N02CC01, sumatriptan, The risk or severity of serotonin syndrome can be increased when Sumatriptan is combined with Fenfluramine.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Fenfluramine.]
[J01MA05, temafloxacin, The metabolism of Fenfluramine can be decreased when combined with Temafloxacin.]
[D01BA02, terbinafine, The metabolism of Fenfluramine can be decreased when combined with Terbinafine.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Fenfluramine.]
[A08AB01, orlistat, Orlistat can cause a decrease in the absorption of Fenfluramine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tetrazepam.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Thiocolchicoside.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Thiopropazate.]
[G04BD01, emepronium, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The risk or severity of serotonin syndrome can be increased when Tianeptine is combined with Fenfluramine.]
[N05BA23, tofisopam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tofisopam.]
[N06AG03, toloxatone, The risk or severity of serotonin syndrome can be increased when Toloxatone is combined with Fenfluramine.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Fenfluramine.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Fenfluramine.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Loprazolam.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Chloral hydrate.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Triclofos.]
[A03AB08, tridihexethyl, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Trimethobenzamide.]
[N04AA12, tropatepine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Fenfluramine.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Urapidil.]
[J01MA04, enoxacin, The metabolism of Fenfluramine can be decreased when combined with Enoxacin.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Veralipride.]
[L01CA04, vinorelbine, The metabolism of Fenfluramine can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Epinastine.]
[N06AX16, venlafaxine, The risk or severity of serotonin syndrome can be increased when Venlafaxine is combined with Fenfluramine.]
[N05CF02, zolpidem, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Zonisamide.]
[N05CF01, zopiclone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Zopiclone.]
[N05AX11, zotepine, The risk or severity of serotonin syndrome can be increased when Zotepine is combined with Fenfluramine.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Guanfacine.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Moricizine.]
[G02AB03, ergonovine, The risk or severity of serotonin syndrome can be increased when Ergometrine is combined with Fenfluramine.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Fenfluramine.]
[N02CA02, ergotamine, The risk or severity of serotonin syndrome can be increased when Ergotamine is combined with Fenfluramine.]
[N03AG01, valproic acid, The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Fenfluramine.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Estazolam.]
[H05BX01, cinacalcet, The metabolism of Fenfluramine can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, The metabolism of Estradiol can be increased when combined with Fenfluramine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Fenfluramine can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, The metabolism of Fenfluramine can be decreased when combined with Ethambutol.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Fenfluramine.]
[C01CA15, gepefrine, The risk or severity of serotonin syndrome can be increased when Gepefrine is combined with Fenfluramine.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Fenfluramine.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be increased when combined with Fenfluramine.]
[N04AA05, profenamine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Ethosuximide.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Ethotoin.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of serotonin syndrome can be increased when Ethylmorphine is combined with Fenfluramine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Etidocaine.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Fenfluramine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Fenfluramine.]
[N05AE03, sertindole, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Sertindole.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Fenfluramine.]
[R06AX12, terfenadine, The metabolism of Fenfluramine can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Fenfluramine can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The risk or severity of serotonin syndrome can be increased when Fluvoxamine is combined with Fenfluramine.]
[C01BB03, tocainide, The metabolism of Tocainide can be decreased when combined with Fenfluramine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Fenfluramine.]
[A02BA03, famotidine, The metabolism of Fenfluramine can be decreased when combined with Famotidine.]
[P02CA03, albendazole, The serum concentration of Fenfluramine can be decreased when it is combined with Albendazole.]
[C08CA02, felodipine, The metabolism of Fenfluramine can be decreased when combined with Felodipine.]
[S01AA13, fusidic acid, The metabolism of Fenfluramine can be decreased when combined with Fusidic acid.]
[J01MB04, pipemidic acid, The metabolism of Fenfluramine can be decreased when combined with Pipemidic acid.]
[N07XX04, sodium oxybate, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Fenfluramine.]
[N02AB03, fentanyl, The risk or severity of serotonin syndrome can be increased when Fentanyl is combined with Fenfluramine.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Fenfluramine.]
[G04BD02, flavoxate, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Fenfluramine.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Flunarizine.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Flunitrazepam.]
[N06AA14, melitracen, The risk or severity of serotonin syndrome can be increased when Melitracen is combined with Fenfluramine.]
[V03AZ01, ethanol, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC02, fluorouracil, The metabolism of Fenfluramine can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The serum concentration of Fenfluramine can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Fluphenazine.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Flurazepam.]
[N05AG01, fluspirilene, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Fluspirilene.]
[L02BB01, flutamide, The metabolism of Fenfluramine can be decreased when combined with Flutamide.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Fenfluramine.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Alcuronium.]
[G01AX06, furazolidone, The risk or severity of serotonin syndrome can be increased when Furazolidone is combined with Fenfluramine.]
[J05AE10, darunavir, The metabolism of Fenfluramine can be decreased when combined with Darunavir.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Fenfluramine is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Amisulpride.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Fenfluramine.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Gallamine.]
[S01AD09, ganciclovir, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Ganciclovir.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Barbexaclone.]
[N06AX08, bifemelane, The risk or severity of serotonin syndrome can be increased when Bifemelane is combined with Fenfluramine.]
[C10AB04, gemfibrozil, The metabolism of Fenfluramine can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Fenfluramine.]
[N04BC06, cabergoline, The risk or severity of serotonin syndrome can be increased when Cabergoline is combined with Fenfluramine.]
[C01CA21, cafedrine, Fenfluramine may increase the excretion rate of Cafedrine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Methsuximide.]
[G03XA02, gestrinone, The metabolism of Gestrinone can be increased when combined with Fenfluramine.]
[N01AH02, alfentanil, The risk or severity of serotonin syndrome can be increased when Alfentanil is combined with Fenfluramine.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Dexmedetomidine.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Glutethimide.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Fenfluramine.]
[L01EX02, sorafenib, The metabolism of Fenfluramine can be decreased when combined with Sorafenib.]
[C07AB09, esmolol, The metabolism of Esmolol can be decreased when combined with Fenfluramine.]
[B01AA12, fluindione, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Fluindione.]
[P01BX01, halofantrine, The metabolism of Fenfluramine can be decreased when combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Fenfluramine.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Halothane.]
[N05AH04, quetiapine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Quetiapine.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Iprazochrome.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Fenfluramine.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Allobarbital.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Hexobarbital.]
[J05AG01, nevirapine, The serum concentration of Fenfluramine can be decreased when it is combined with Nevirapine.]
[R05DA03, hydrocodone, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Fenfluramine can be increased when combined with Hydrocortisone.]
[G04BD06, propiverine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Hydroxychloroquine.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Prothipendyl.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[J04AB04, rifabutin, The metabolism of Fenfluramine can be increased when combined with Rifabutin.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Fenfluramine.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Fenfluramine.]
[H01AC02, somatrem, The metabolism of Fenfluramine can be increased when combined with Somatrem.]
[N01AH03, sufentanil, The risk or severity of serotonin syndrome can be increased when Sufentanil is combined with Fenfluramine.]
[N06AA02, imipramine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Imipramine.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Tizanidine.]
[L01CE01, topotecan, Fenfluramine may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.]
[L03AB04, interferon alfa-2a, The metabolism of Fenfluramine can be decreased when combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The metabolism of Fenfluramine can be decreased when combined with Interferon alfa-2b.]
[N06AX17, milnacipran, The risk or severity of serotonin syndrome can be increased when Milnacipran is combined with Fenfluramine.]
[A03AA30, piperidolate, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Articaine.]
[V08AB02, iohexol, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Iohexol.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Alprazolam is combined with Fenfluramine.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Ramelteon.]
[R06AE01, buclizine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C10AA06, cerivastatin, The metabolism of Fenfluramine can be decreased when combined with Cerivastatin.]
[L01XX35, anagrelide, The metabolism of Fenfluramine can be decreased when combined with Anagrelide.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Alprenolol.]
[L03AB09, interferon alfacon-1, The metabolism of Fenfluramine can be decreased when combined with Interferon alfacon-1.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Fenfluramine.]
[N06AA13, iprindole, The risk or severity of serotonin syndrome can be increased when Iprindole is combined with Fenfluramine.]
[N06AF05, iproniazid, The risk or severity of serotonin syndrome can be increased when Iproniazid is combined with Fenfluramine.]
[J05AB13, penciclovir, The metabolism of Fenfluramine can be decreased when combined with Penciclovir.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, The risk or severity of serotonin syndrome can be increased when Isocarboxazid is combined with Fenfluramine.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Isoflurane.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Entacapone is combined with Fenfluramine.]
[J04AC01, isoniazid, The risk or severity of serotonin syndrome can be increased when Isoniazid is combined with Fenfluramine.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Fenfluramine.]
[H01AC01, somatropin, The metabolism of Fenfluramine can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Fenfluramine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Ketamine.]
[C02KD01, ketanserin, The risk or severity of serotonin syndrome can be increased when Ketanserin is combined with Fenfluramine.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Fenfluramine.]
[J02AB02, ketoconazole, The metabolism of Fenfluramine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Olanzapine.]
[V03AC03, deferasirox, The serum concentration of Fenfluramine can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Fenfluramine can be increased when combined with Abatacept.]
[N04BC09, rotigotine, The risk or severity of serotonin syndrome can be increased when Rotigotine is combined with Fenfluramine.]
[J01MB02, nalidixic acid, The metabolism of Fenfluramine can be decreased when combined with Nalidixic acid.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Fenfluramine.]
[N04BB01, amantadine, The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Fenfluramine.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Lacosamide.]
[G03AD01, levonorgestrel, The metabolism of Levonorgestrel can be increased when combined with Fenfluramine.]
[N04BA01, levodopa, The risk or severity of serotonin syndrome can be increased when Levodopa is combined with Fenfluramine.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Fenfluramine can be increased when combined with Armodafinil.]
[N02CA07, lisuride, The risk or severity of serotonin syndrome can be increased when Lisuride is combined with Fenfluramine.]
[N06AA07, lofepramine, The risk or severity of serotonin syndrome can be increased when Lofepramine is combined with Fenfluramine.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Lorazepam is combined with Fenfluramine.]
[C10AA02, lovastatin, The metabolism of Fenfluramine can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Loxapine.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be increased when combined with Fenfluramine.]
[L01EG01, temsirolimus, The metabolism of Fenfluramine can be decreased when combined with Temsirolimus.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Fenfluramine can be increased when used in combination with Magnesium sulfate.]
[N06AA21, maprotiline, The risk or severity of serotonin syndrome can be increased when Maprotiline is combined with Fenfluramine.]
[A08AA05, mazindol, The risk or severity of serotonin syndrome can be increased when Mazindol is combined with Fenfluramine.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Meclizine.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Medazepam.]
[P01BC02, mefloquine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Mefloquine.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Melatonin.]
[N06DX01, memantine, The metabolism of Fenfluramine can be decreased when combined with Memantine.]
[N02AB02, meperidine, The risk or severity of serotonin syndrome can be increased when Meperidine is combined with Fenfluramine.]
[C01CA11, mephentermine, The risk or severity of serotonin syndrome can be increased when Mephentermine is combined with Fenfluramine.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Mephenytoin is combined with Fenfluramine.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Mepivacaine.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Fenfluramine.]
[N02AX05, meptazinol, The risk or severity of serotonin syndrome can be increased when Meptazinol is combined with Fenfluramine.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Mesoridazine.]
[N05AX13, paliperidone, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Paliperidone.]
[A04AA04, dolasetron, The risk or severity of serotonin syndrome can be increased when Dolasetron is combined with Fenfluramine.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Fenfluramine.]
[N06BA03, methamphetamine, The risk or severity of serotonin syndrome can be increased when Metamfetamine is combined with Fenfluramine.]
[A03AB07, methantheline, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Methapyrilene.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Methaqualone.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Fenfluramine.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Metergoline.]
[H03BB02, methimazole, The metabolism of Fenfluramine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, The metabolism of Pemetrexed can be decreased when combined with Fenfluramine.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Fenfluramine.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Methohexital is combined with Fenfluramine.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Fenfluramine is combined with Ziconotide.]
[N05AA02, methotrimeprazine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Methotrimeprazine.]
[D05BA02, methoxsalen, The metabolism of Fenfluramine can be decreased when combined with Methoxsalen.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Methoxyflurane.]
[V04CG05, methylene blue, Fenfluramine may increase the serotonergic activities of Methylene blue.]
[R03DA05, aminophylline, Fenfluramine may increase the excretion rate of Aminophylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA04, methylphenidate, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Methylphenidate.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Fenfluramine.]
[G03EK01, methyltestosterone, The metabolism of Methyltestosterone can be decreased when combined with Fenfluramine.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Methyprylon.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Fenfluramine.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Fenfluramine.]
[C07AB02, metoprolol, The metabolism of Fenfluramine can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Metronidazole.]
[C01BB02, mexiletine, The metabolism of Fenfluramine can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Mianserin.]
[S02AA13, miconazole, The metabolism of Fenfluramine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Fenfluramine.]
[N05CD08, midazolam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Mifepristone can be increased when combined with Fenfluramine.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[N06BA12, lisdexamfetamine, The risk or severity of serotonin syndrome can be increased when Lisdexamfetamine is combined with Fenfluramine.]
[N05AE02, molindone, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Molindone.]
[C01BD01, amiodarone, The metabolism of Fenfluramine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Fenfluramine.]
[N02AA01, morphine, The risk or severity of serotonin syndrome can be increased when Morphine is combined with Fenfluramine.]
[A04AA05, palonosetron, The risk or severity of serotonin syndrome can be increased when Palonosetron is combined with Fenfluramine.]
[L04AB05, certolizumab pegol, The metabolism of Fenfluramine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Fenfluramine.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Fenfluramine.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Vecuronium.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Amobarbital.]
[G03XC01, raloxifene, The metabolism of Fenfluramine can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Amoxapine.]
[N03AB05, fosphenytoin, The serum concentration of Fenfluramine can be decreased when it is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The metabolism of Fenfluramine can be decreased when combined with Interferon beta-1b.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Fenfluramine.]
[N04BC04, ropinirole, Fenfluramine may increase the sedative activities of Ropinirole.]
[J01CF06, nafcillin, The metabolism of Fenfluramine can be increased when combined with Nafcillin.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Naftidrofuryl.]
[N02AF02, nalbuphine, The risk or severity of serotonin syndrome can be increased when Nalbuphine is combined with Fenfluramine.]
[N07BB04, naltrexone, The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Fenfluramine.]
[L04AC03, anakinra, The metabolism of Fenfluramine can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The risk or severity of serotonin syndrome can be increased when Amphetamine is combined with Fenfluramine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Fenfluramine.]
[A10BG01, troglitazone, The metabolism of Fenfluramine can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of serotonin syndrome can be increased when Duloxetine is combined with Fenfluramine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Fenfluramine.]
[N01AH06, remifentanil, The risk or severity of serotonin syndrome can be increased when Remifentanil is combined with Fenfluramine.]
[N05AX14, iloperidone, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Iloperidone.]
[J02AA01, amphotericin B, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Amphotericin B.]
[N06AX23, desvenlafaxine, The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Fenfluramine.]
[C10AD02, niacin, The metabolism of Fenfluramine can be decreased when combined with Niacin.]
[N06AF02, nialamide, The risk or severity of serotonin syndrome can be increased when Nialamide is combined with Fenfluramine.]
[C08CA04, nicardipine, The metabolism of Fenfluramine can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Fenfluramine.]
[P02DA01, niclosamide, The metabolism of Fenfluramine can be decreased when combined with Niclosamide.]
[N07BA01, nicotine, The metabolism of Fenfluramine can be decreased when combined with Nicotine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Fenfluramine.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Nitrazepam.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Zaleplon.]
[N04BC05, pramipexole, Fenfluramine may increase the sedative activities of Pramipexole.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Nitrous oxide.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Nomifensine.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be increased when combined with Fenfluramine.]
[S01AE02, norfloxacin, The metabolism of Fenfluramine can be decreased when combined with Norfloxacin.]
[G03AC07, norgestrienone, The metabolism of Norgestrienone can be increased when combined with Fenfluramine.]
[N06AA10, nortriptyline, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Nortriptyline.]
[L03AB07, interferon beta-1a, The metabolism of Fenfluramine can be decreased when combined with Interferon beta-1a.]
[L04AC04, rilonacept, The metabolism of Fenfluramine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Fenfluramine can be increased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of serotonin syndrome can be increased when Opipramol is combined with Fenfluramine.]
[N02AA02, opium, The risk or severity of serotonin syndrome can be increased when Opium is combined with Fenfluramine.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Fenfluramine.]
[P02BA02, oxamniquine, The metabolism of Fenfluramine can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Oxazepam.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Fenfluramine.]
[N02AA11, oxymorphone, The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Fenfluramine.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Oxypertine.]
[A03AB03, oxyphenonium, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[N05AH05, asenapine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Asenapine.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Fenfluramine.]
[M03AC01, pancuronium, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[G03DB06, chlormadinone, The metabolism of Chlormadinone can be increased when combined with Fenfluramine.]
[N05CC05, paraldehyde, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[C02KC01, pargyline, The risk or severity of serotonin syndrome can be increased when Pargyline is combined with Fenfluramine.]
[J01MA03, pefloxacin, The metabolism of Fenfluramine can be decreased when combined with Pefloxacin.]
[G04BD11, fesoterodine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Penbutolol.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Penfluridol.]
[N02AD01, pentazocine, The risk or severity of serotonin syndrome can be increased when Pentazocine is combined with Fenfluramine.]
[N05CA01, pentobarbital, The risk or severity of adverse effects can be increased when Pentobarbital is combined with Fenfluramine.]
[C04AD03, pentoxifylline, Fenfluramine may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Perazine.]
[N04BC02, pergolide, The risk or severity of serotonin syndrome can be increased when Pergolide is combined with Fenfluramine.]
[C08EX02, perhexiline, The metabolism of Fenfluramine can be decreased when combined with Perhexiline.]
[N05AB03, perphenazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Fenfluramine.]
[N02AD02, phenazocine, The risk or severity of serotonin syndrome can be increased when Phenazocine is combined with Fenfluramine.]
[N06AF03, phenelzine, The risk or severity of serotonin syndrome can be increased when Phenelzine is combined with Fenfluramine.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Fenfluramine.]
[B01AA02, phenindione, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Phenindione.]
[N03AA02, phenobarbital, The serum concentration of Fenfluramine can be decreased when it is combined with Phenobarbital.]
[N01AH04, phenoperidine, The risk or severity of serotonin syndrome can be increased when Phenoperidine is combined with Fenfluramine.]
[B01AA04, phenprocoumon, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Phenprocoumon.]
[A08AA01, phentermine, The risk or severity of serotonin syndrome can be increased when Phentermine is combined with Fenfluramine.]
[S01GA05, phenylephrine, The metabolism of Fenfluramine can be increased when combined with Phenylephrine.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Phenylpropanolamine.]
[N03AB02, phenytoin, The serum concentration of Fenfluramine can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Fenfluramine can be increased when combined with Golimumab.]
[C08CX01, mibefradil, The metabolism of Fenfluramine can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Fenfluramine.]
[C07AA03, pindolol, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Pindolol.]
[J05AE01, saquinavir, The metabolism of Fenfluramine can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Fenfluramine.]
[N05AC04, pipothiazine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Pipotiazine.]
[A02BX03, pirenzepine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of serotonin syndrome can be increased when Piritramide is combined with Fenfluramine.]
[J01MA11, grepafloxacin, The metabolism of Fenfluramine can be decreased when combined with Grepafloxacin.]
[N02CX01, pizotyline, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Pizotifen.]
[J05AG02, delavirdine, The metabolism of Fenfluramine can be decreased when combined with Delavirdine.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Proxibarbal.]
[A03AE01, alosetron, The metabolism of Fenfluramine can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Fenfluramine can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The metabolism of Fenfluramine can be decreased when combined with Ritonavir.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Fenfluramine.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Prazepam.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Fenfluramine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Fenfluramine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Fenfluramine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The serum concentration of Fenfluramine can be decreased when it is combined with Primidone.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Fenfluramine.]
[S01HA05, procaine, The risk or severity of serotonin syndrome can be increased when Procaine is combined with Fenfluramine.]
[L01XB01, procarbazine, The risk or severity of serotonin syndrome can be increased when Procarbazine is combined with Fenfluramine.]
[N05AB04, prochlorperazine, The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Fenfluramine.]
[N04AA04, procyclidine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Progesterone can be increased when combined with Fenfluramine.]
[N05AA03, promazine, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Promazine.]
[R06AD02, promethazine, The risk or severity of serotonin syndrome can be increased when Promethazine is combined with Fenfluramine.]
[C01BC03, propafenone, The metabolism of Fenfluramine can be decreased when combined with Propafenone.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Propanidid.]
[A03AB05, propantheline, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Periciazine.]
[N05CM06, propiomazine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Fenfluramine.]
[N01AX10, propofol, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Propofol.]
[N02AC04, propoxyphene, The risk or severity of serotonin syndrome can be increased when Dextropropoxyphene is combined with Fenfluramine.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Fenfluramine.]
[N02CC04, rizatriptan, The risk or severity of serotonin syndrome can be increased when Rizatriptan is combined with Fenfluramine.]
[N06AA11, protriptyline, The risk or severity of serotonin syndrome can be increased when Protriptyline is combined with Fenfluramine.]
[R01BA02, pseudoephedrine, The risk or severity of serotonin syndrome can be increased when Pseudoephedrine is combined with Fenfluramine.]
[N05AX12, aripiprazole, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Aripiprazole.]
[A03AB15, diphemanil, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Fenfluramine.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Vinbarbital.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Captodiame.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Styramate.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Pyrantel.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Mepyramine.]
[C01BA01, quinidine, The metabolism of Fenfluramine can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Fenfluramine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Fenfluramine can be decreased when combined with Ranitidine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Fenfluramine.]
[J04AB02, rifampin, The serum concentration of Fenfluramine can be decreased when it is combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Oxitriptan.]
[S01FA02, scopolamine, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, The risk or severity of adverse effects can be increased when Secobarbital is combined with Fenfluramine.]
[N04BD01, selegiline, The risk or severity of serotonin syndrome can be increased when Selegiline is combined with Fenfluramine.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Fenfluramine.]
[H02CA04, levoketoconazole, The metabolism of Fenfluramine can be decreased when combined with Levoketoconazole.]
[D11AX02, gamma-linolenic acid, The therapeutic efficacy of Fenfluramine can be decreased when used in combination with Gamolenic acid.]
[R03BB01, ipratropium bromide, Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
